Here are five details:
1. At the end of the quarter, the company recorded $2 billion in sales, a 3 percent increase year-over-year.
2. Within its knee segment, Zimmer Biomet’s sales topped $703 million, a 3.4 percent increase compared to the same quarter in 2017.
3. Zimmer Biomet’s hip segment generated $487 million in sales, a 4 percent increase year-over-year.
4. Here is Zimmer Biomet’s geographic sales breakdown:
• Americas — $1.22 billion
• EMEA — $458 million
• Asia Pacific — $334 million
5. The company’s spine business also generated $198 million in sales, a 2.5 percent increase year-over-year.
To view the full financial report, click here.
More articles on devices and implants:
CarboFix spine screw system receives FDA clearance: 3 things to know
Orthopedic devices market estimated to hit $65M by 2026: 4 key report takeaways
Implanet’s new subsidiary targets $300M market: 4 things to know
